Nathan Howlett, DO
Sports Medicine · Warwick, RINPI 1225444607
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.6%), speaking fees and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 46.4% of the total. Reporting peaked in 2024 at $5,564 and has fallen 68.2% since, to $1,770 in 2025.
Across 84 payments — averaging $219.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$9K
- Kairos Surgical Inc$5K
- Stryker$4K
- FX Shoulder Solutions, Inc$443
- Bioventus LLC$132
- Ferring Pharmaceuticals Inc.$76
- plus $181 from 6 others
What the payments were for
- Speaking & faculty fees$5,00027%
- Travel & lodging$6,93938%
- Food & beverage$2,94016%
- Education$3,60019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $8,577 |
| Kairos Surgical Inc | 17 | $4,833 |
| Stryker | 32 | $4,237 |
| FX Shoulder Solutions, Inc | 1 | $443 |
| Bioventus LLC | 5 | $132 |
| Ferring Pharmaceuticals Inc. | 4 | $76 |
| Pacira Pharmaceuticals Incorporated | 2 | $64 |
| Vertex | 1 | $32 |
| Johnson & Johnson | 1 | $26 |
| Abbott | 1 | $23 |
| Acera Surgical, Inc. | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,204
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,242
- TRIDENT$147
- AXSOS$147
- REUNION$147
- AEQUALIS FLEX REVIVE$102
How this compares
$18,479 in reported general payments places this provider in the 80th percentile of 28 sports medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 272 | $733 |
| Tranexamic Acid | 105 | $576 |
| Diclofenac Sodium | 14 | $510 |
| Methylprednisolone | 57 | $440 |
| Omeprazole | 122 | $158 |
| Amoxicillin | 40 | $91 |
| Gabapentin | 13 | $85 |
| Cyclobenzaprine Hcl | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Warwick
- Franklin MirrerWarwick$10K
- Abhay MathurWarwick$5K
- Vincent YakavonisWarwick$46
- Andrew GreenProvidence$1.8M
- Brett OwensEast Providence$273K
- Keith MonchikProvidence$144K
- David MossJohnston$123K
- Mohit KukrejaProvidence$23K
- Matthew PlanteProvidence$15K
- Robert ShalvoyProvidence$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.